Fritz H
Abteilung für Klinische Chemie und Klinische Biochemie, Chirurgischen Klinik Innenstadt, Universität München.
Biol Chem Hoppe Seyler. 1988 May;369 Suppl:79-82.
Human mucous secretions contain a proteinase inhibitor which is produced locally and inhibits, besides trypsin and chymotrypsin, granulocytic elastase and cathepsin G as well as mast cell chymase and tryptase. The various inhibitors isolated from different sources (bronchial mucus, parotid secretion, seminal plasma, cervical mucus, etc.) and named accordingly (bronchial mucus inhibitor, BMI; human seminal inhibitor I, HUSI-I; cervical mucus inhibitors, CUSI; antileukoprotease, ALP; secretory leukocyte protease inhibitor, SLPI) proved to be identical or derived from a mature inhibitory protein encoded by a single gene of the human genom. Therefore, this inhibitor should be named mucus proteinase inhibitor, MPI. Such a neutral terminus would help to avoid misleading interpretations of already published data and also of the biological role of this inhibitory protein because the MPI may serve several and different physiological functions.
人类黏液分泌物含有一种蛋白酶抑制剂,它在局部产生,除了抑制胰蛋白酶和糜蛋白酶外,还能抑制粒细胞弹性蛋白酶、组织蛋白酶G以及肥大细胞糜酶和胰蛋白酶。从不同来源(支气管黏液、腮腺分泌物、精浆、宫颈黏液等)分离出的各种抑制剂并因此命名(支气管黏液抑制剂,BMI;人类精浆抑制剂I,HUSI-I;宫颈黏液抑制剂,CUSI;抗白细胞蛋白酶,ALP;分泌型白细胞蛋白酶抑制剂,SLPI),结果证明它们是相同的,或者源自人类基因组单个基因编码的成熟抑制蛋白。因此,这种抑制剂应命名为黏液蛋白酶抑制剂,MPI。这样一个中性的名称将有助于避免对已发表数据以及这种抑制蛋白的生物学作用产生误导性解释,因为MPI可能具有多种不同的生理功能。